Specialties

The use of SGLT2 inhibitors was associated with reduced risk of any cause of death in patients with or without a history of major cardiovascular disease.

Trying to determine modifiable risk factors for gestational diabetes (GDM) is not only beneficial for the mother, but also for protecting the baby.  

Patients with type 2 diabetes and poor glycemic control are more likely to have a lower cognitive function, but what role could a Mediterranean diet have?

Younger patients with diabetes face increased risk of death.

Metformin is one of the oldest antihyperglycemic drugs still in practice, but recent research confirms its benefits.

Getting patients to new standard CGM targets will prevent complications and hypoglycemia.

Could a newer diabetes medication provided clinicians with an alternative when managing heart failure?

Does intensive glucose control show heart benefits in long-term followup?. 

How to identify who is at risk for the progression of diabetic kidney disease to end-stage renal disease?

New research attempts to untangle the conflicting literature on whether statins and SSTIs are linked.